Skip to main content
Home

Main navigation

  • Home
  • Series
  • People
  • Depts & Colleges

Main navigation

  • Home
  • Series
  • People
  • Depts & Colleges

A Pharma perspective on healthcare needs and innovation in drug discovery

Series
Pharmaceutical Industry: Past, Present and Future
Audio Embed
The third Green Templeton Lecture 2009 explores how, by harnessing innovation to meet unmet medical needs, pharma companies can deliver significant value to patients, payers and shareholders.
The Green Templeton Lectures 2009 explored the theme 'Addicted to Big Pharma? Reconciling business, medical and ethical needs' in a series of four lectures looking at the pharmaceutical industry past, present and future. This third lecture was delivered by Patrick Vallance (Head of Drug Discovery; GlaxoSmithKline) Philip Bloomer (Director of Campaigns; Oxfam)

More in this series

View Series
Pharmaceutical Industry: Past, Present and Future

Pharmaceutical Industry: Origin and Evolution

Tilli Tansey, Professor of History of Modern Medical Sciences, University College London traces the evolution of the modern pharmaceutical industry from the mid nineteenth century to the final decades of the twentieth century.
Previous

Episode Information

Series
Pharmaceutical Industry: Past, Present and Future
People
Patrick Vallance
Philip Bloomer
Keywords
drugs
pharmaceutical
green templeton
Medicine
college
Department: Green Templeton College
Date Added: 09/06/2009
Duration: 00:57:58

Subscribe

Apple Podcast Audio Audio RSS Feed

Download

Download Audio

Footer

  • About
  • Accessibility
  • Contribute
  • Copyright
  • Contact
  • Privacy
'Oxford Podcasts' Twitter Account @oxfordpodcasts | MediaPub Publishing Portal for Oxford Podcast Contributors | Upcoming Talks in Oxford | © 2011-2022 The University of Oxford